- Details
- Description
Strength:
20mg
Composition:
Cabozantinib INN 20 mg
Treatment:
Oncology / anticancer
Brand:
Caboxen 20
Quantity Unit:
Cabozantinib 20
Manufacturer:
Everest Pharmaceuticals Ltd.
Caboxen 20 is an oncology medicine manufactured by Everest Pharmaceuticals Ltd., containing Cabozantinib INN 20 mg. Cabozantinib is an oral targeted anticancer medicine that belongs to the tyrosine kinase inhibitor (TKI) class. It works by inhibiting several receptor tyrosine kinases involved in tumor growth, blood-vessel formation, and cancer progression. Cabozantinib is used in the treatment of certain types of cancer according to the approved indication and the treating physician’s assessment. Everest Pharmaceuticals lists Caboxen 20 and Caboxen 80 in its oncology portfolio.
